Notably, aberrant genomic DNA methylation in NSCLC tumor-associated fibroblasts is a critical regulator of tumor progression, with SMAD3 promoter hypermethylation associated with reduced gene expression [41]. This evidence concerns the gene SMAD3 and non-small cell lung carcinoma.